ABSTRACT
1
The emergence of fentanyl and its analogs and their infiltration into the non-prescription drug supply is central to the crisis, accounting for approximately 75% of accidental opioid-related deaths in Canada in the last few years.
1 Importantly, a similar proportion of deaths have also been found to involve multiple substances, including one or more opioids as well as non-opioid substances such as alcohol, benzodiazepines, methamphetamine, or cocaine. 1 As communities, first responder organizations, health authorities and governments attempt to respond, multi-pillared strategies are often adopted, highlighting a balance of attention to prevention, harm reduction, treatment, and enforcement. [3] [4] [5] Given the sheer magnitude of the crisis and escalating death toll, the mobilization of harm reduction interventions is often viewed as a particularly immediate priority (e.g., 6 ). Harm reduction is considered a pragmatic public health approach that aims to reduce the harms associated with risky health behaviours. 7, 8 In the case of drug use, its primary emphasis tends to be the prevention of death and disability without requiring that substance use be discontinued. At its core, harm reduction supports any steps in the right direction, takes a value-neutral position on the question of drug use, and is complementary to prevention and treatment strategies. [7] [8] [9] [10] Although still growing and lacking somewhat in high-quality randomized trials, the evidence to date is sound and suggestive of positive efficacy -particularly for its ability to save lives, reduce HIV and HCV infection risk, increase access to health and social services, and provide a pathway to recovery. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] With respect to Canada's current crisis, common harm reduction discussions include the provision of venues for safe consumption; ensuring the widespread availability of emergency relief to the public (e.g., naloxone), as well as training first responders and other frontline workers to administer emergency relief in the event of overdose or poisoning; the distribution of sterilized supplies (e.g., needles); and public education and messaging on the risks of opioidrelated poisoning or overdose, including the dangers of using alone. 5, 6, 8, 17 Greater access and availability of medication maintenance therapies are also often emphasized as an important aspect of harm reduction, even though it is perhaps more accurate to understand this as a treatment modality, given the evidence base indicating its efficacy in this regard. [7] [8] [9] [10] [11] 13, 16 One area where little is currently known is that of the role of stigmatization, particularly in terms of how this might impact the uptake of various harm reduction strategies among users, as well as the endorsement of harm reduction initiatives among frontline providers. To this end, Opening Minds, the anti-stigma initiative of the Mental Health Commission of Canada, undertook a research project in partnership with funding from Health Canada to understand and explain the qualities, characteristics, sources, consequences, and solutions to the problem of stigmatization on the front-lines of the opioid crisis. Within this broader objective, perspectives on the successes and challenges of harm reduction were of interest. As such, this paper reports on findings from this larger study specifically related to the topic of harm reduction. A narrative summary of opioid stigma and its management, undertaken as part of this project, was also recently published. e10 this theoretical understanding, power is both central and necessary, allowing these processes to unfold.
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MeThodS
Ethics approval for the study was received from both the University of Calgary Conjoint Health Research Ethics Board and the Queen's University Health Sciences and Affiliated Teaching Hospitals Research Ethics Board. The study used a qualitative key informant methodology. 20 Key informants, because of their personal knowledge, experience, or position within a society or in relation to a particular phenomenon, are able to provide more information and a deeper insight into what is going on around them. This method was identified as being well-suited to the aims of the current study. 20 Our main key informant groups were frontline healthcare staff, police services, paramedics, fire services, other frontline service providers (such as outreach workers, for example), people involved in policy development and/or service delivery decisions at various community and government levels, as well as people with lived experience of opioid or other drug use problems. Because we were interested in experiences and perspectives regarding stigmatization and harm reduction across multiple domains -as well as to better understand how stigma might show up in terms of access, usage, and endorsement of various harm reduction practices and protocols -we felt it was important to include the perspectives of both providers as well as people with lived experience of opioid or other drug use.
Key informants were identified through a combination of purposive (i.e., by region and first responder type) and convenience (i.e., availability and willingness to participate) sampling. Data collection methods included focus groups and one-on-one key informant interviews. Focus groups sites were selected to ensure: (a) representation from each of Canada's five main regions; (b) a selection of some sites where opioidrelated deaths or hospitalizations have been identified as being particularly high and some where the crisis was not yet being as strongly felt; and (c) that we were able to gather information from a number of different key informant perspectives (e.g., frontline health professionals, police services and fire services) to ensure appropriate rigour in data triangulation. 21 Site selection also aimed to reflect higher and lower levels of population density as well as reasonable geographic diversity. Focus groups were held in Vancouver and the lower mainland area (British Columbia region), Winnipeg (Prairies region), Calgary (Prairies region), Toronto (Ontario region), Quebec City (Quebec region), St. John's (Atlantic region).
All focus groups were conducted in person. Respondents for one-on-one key informant interviews were identified via snowball sampling, mainly through contacts from focus group sites, and were selected based on the identification of additional information needs arising from the focus group data or themes identified in the focus group data that had not yet achieved saturation. With the exception of two key informant interviews that were completed in person, all interviews were completed by telephone.
An unstructured interview protocol was used, with introductions and prompts for four main topics of discussion -key issues with drug use and opioid poisoning in the community, how opioid use is different or not different from other kinds of drug use problems, what stigma looks like and how it gets in the way of helping people with opioid use problems, and the identification of learning needs and promising practices for tackling the main barriers and challenges related to stigmatization. All focus groups and interviews were tape recorded with participants' permission and transcribed by a third party.
Transcribed discussions from focus groups and interviews were organized by topic to facilitate the coding and analysis process. Data were analyzed using a thematic approach, using steps outlined by Braun and Clarke, 22 and include: (1) data familiarization/immersion; (2) Initial code generation; (3) Interpretative analysis of collated codes into main themes and subthemes; (4) Reviewing of themes in relation to coded extracts and generation of a thematic map; (5) Refining and defining themes and potential subthemes to further unify the emerging story of the data; and (6) Reporting the results of the analysis in a way that demonstrates the merit and validity of the analysis by using appropriate extract examples that relate to the themes, the research question(s), and the existing literature. Transcribed discussions from focus e11 groups and interviews were organized by question to facilitate the coding and analysis process. 22 Analysis was facilitated with the use of the qualitative software MAXQDA (version 18.0.7). 23 All coding and analyses were conducted independently by the first and last author.
The results presented below pertain to findings related to stigmatization and harm reduction among first responders and health and social care providers in the context of the opioid crisis. Findings pertaining to the stigmatization of people with lived experience of opioid or other drug use in the context of harm reduction are not included in this analysis. Any extracts used in reporting the results have had personal identifiers removed in order to retain the promise of participant anonymity. Excerpts are indicated simply as either 'key informant interview' participant or 'focus group participant.' 
ReSuLTS
A total of eight focus groups were conducted between January and March 2018, six with first responder groups and two with people with lived experience of opioid or other drug use problems (see Table 1 ). In addition, 15 key informant interviews were completed between January and July 2018, at which point saturation was reached (Table 1) . Results of the analysis are presented in two main sections -findings explicating the process of stigmatization specific to providers (Figure 1 ), and findings outlining proposed solutions ( Figure 2 ).
The Problem of Low Compassion SatisfactionThe Uniting Theme
Low compassion satisfaction emerged as the central problem to the question of 'how stigma shows up' on the front lines of the opioid crisis among providers ( Figure 1 ). It was described using terms such as frustration and/or apathy, descriptions of emotional and clinical distancing from clients, and experiences of providing lower overall quality care and response. The following comments illustrate: Importantly, these experiences were described as being informed by and coalescing around, three main themes or problems, which emerged as the main drivers of stigmatization in relation to harm reduction and the opioid crisis for providers. They are:
• Negative beliefs about people with opioid and other drug use problems and ambivalence about harm reduction.
• Low belief in the possibility of wellness and associated feelings of helplessness and hopelessness.
• Practitioner burnout, compassion fatigue, and vicarious trauma.
Each of these themes is described in more detail below.
Negative Beliefs about Addiction and Ambivalent Views about Harm Reduction
Respondents widely agreed that harm reduction measures were both important and effective in helping to keep people alive and to reduce other harms associated with opioid and other drug use. However, many respondents also expressed a high degree of ambivalence about harm reduction techniques and practices -speaking, for example, about emergency relief measures like naloxone being a 'double-edged sword,' and expressing the view that harm reduction practices further enabled addiction and/or encouraged risk behaviours. Resistance to harm reduction was also expressed among some respondents because its purpose is not treatment-based -i.e., because it does not directly address the underlying causes of addiction. As the following comments show:
We Another key tension point relating to stigma and harm reduction pertained to how frontline providers experienced their roles as 'helpers' or 'healers' in the context of harm reduction. Specifically, they expressed frustration about many aspects of harm reduction work, including a feeling that they were not really helping individuals beyond keeping them alive -and that given the sheer magnitude of the current crisis, saving lives often did not generate much sense of helping satisfaction. Central to their experiences was a sense of 'not making a difference', especially in regard to not being able to help move people towards recovery, and in attending to high recidivism clients:
The Importantly, providers' experiences in this regard were also connected to system-level inadequacies. Respondents recognized that their frustrations and feelings of helplessness were also connected to problems with adequate availability and accessibility of services for people with opioid and other drug use problems:
[Addiction and mental health treatment] is seen as not as important, there's no status attached to it unlike if you're working in cardiology or orthopedic surgery. So that's why one of the reasons working conditions are so difficult I think is because they're working with that population. (focus group participant) The indifference is because the way the system goes…You become indifferent when you say, 'because what's going to change from the last time? Nothing, right?' (focus group participant)
PRACTiTioneR BuRnouT, CoMPASSion
FATigue, And ViCARiouS TRAuMA
The third major theme and contributor to low compassion satisfaction that emerged in focus groups and interviews was that of vicarious trauma, compassion fatigue, and burnout from working on the front-lines of the crisis. The stresses and challenges associated with helping high recidivism clients, witnessing multiple numbers of poisonings and poisoning-related fatalities, and struggling with ongoing system inadequacies such as lack of resources, understaffing, and inadequate access to treatment and care for users, were the most commonly described factors.
Respondents also recognized that experiences of vicarious trauma, compassion fatigue, and burnout were a major contributor to low levels of compassion satisfaction and emotional and behavioural distancing from clients. They also recognized that these experiences were negatively impacting their own mental health and wellbeing. The following comments illustrate:
One group asked us to come in and do some training on how to help their people be empathetic and then they said to us, "you know I'm an animal control guy and I go home and kick my dog, like what's with that?" And they don't understand that it's trauma, you know and they're saying, "I'm a good guy, I got kids, why am I going home and yelling at everybody?" and "I'm a good person, why am I doing this?" (focus group participant)
We Importantly, these experiences were described with a greater sense of intensity and urgency among respondents living and working in areas of the country where the crisis was particularly acute.
PRoPoSed SoLuTionS
The proposed solutions identified by respondents for reducing stigma tended to be those that target the three main problems described above and support the overall aim of improving providers' experiences of compassion satisfaction. These solutions are highlighted in Figure 2 and described in more detail below. They include:
• Education to reframe and shift perceptions about addiction and harm reduction • Training in trauma-informed care and practice • Social contact to cultivate belief in wellness combat feelings of helplessness and hopelessness • Inward-facing interventions to build resiliency and support provider mental health.
FIG. 2
Proposed solutions for combatting stigmatization among providers on the front lines of the opioid crisis.
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Reframing Harm Reduction and Addiction
First of all, respondents emphasized a need for interventions that provided greater understanding of the theory and evidence surrounding harm reduction practices and principles. This included emphasizing the role of harm reduction within a larger context of wellness, hope and care -and within a framework that emphasizes addiction as a legitimate medical condition. Ultimately, what respondents described was a need for education that would help reframe perceptions of both harm reduction and addiction away from notions of harm reduction as enabling addiction, and views of addiction as a choice and as a moral failing. Social contact and education were both discussed as useful approaches in this regard. Below are some examples of respondents' comments: 
Use Social Contact to Cultivate a Belief in Wellness and Recovery and to Combat Feelings of Helplessness and Hopelessness
The second theme regarding proposed solutions was to cultivate and foster a greater understanding and belief in the processes of hope, wellness, and recovery from drug use problems and addiction, including an emphasis of the importance of providers' roles in people's experiences. Respondents commonly felt that exposing frontline providers to recovery stories and recovery-based social contact interventions would be a valuable strategy. As the following comments illustrate: Another important priority for combatting stigma was to provide training in trauma-informed practice and care. As illustrated in the following comments, training in trauma-informed practice and care was identified as an important stigma reduction strategy on two fronts -to provide a safer environment in which care and response are provided, as well as a tool or practice that would help first responders in their own work environments deal with vicarious trauma and other stressful experiences:
The 
SuMMARy And ConCLuSionS
The findings from this research revealed several ways in which stigma shows up on the front lines of the opioid crisis among first responders and health and social care providers in the context of harm reduction. Ambivalence about the benefits of harm reduction and negative attitudes about addiction, low belief in the possibility of wellness and associated feelings of feelings of helplessness, and experiences of provider burnout, compassion fatigue and vicarious trauma all emerged as key themes, which coalesced around a more central or core experience -the problem of low compassion satisfaction. Many of these themes, which were described as both feeding off and reinforcing stigmatization of people with opioid and other drug use problems, are consistent with existing research on the stigma of opioid and other drug use. 18 Importantly, however, these findings also extend the literature, particularly in terms of the important connection between the concepts of compassion satisfaction and stigmatization.
The concept of compassion satisfaction is generally understood as professional fulfillment experienced through helping others. [24] [25] [26] It occurs when empathy drives altruistic behaviour on the part of the provider in order to alleviate the suffering of those they are healing. 24 Compassion satisfaction also includes the experiences of hope and optimism, with a desire to continue in the caregiving role. 24 Indeed, burnout and compassion fatigue are both found to be correlated with low levels of compassion satisfaction, as are distancing behaviours. 25, 26 For example, a recent study on compassion satisfaction in UK emergency departments found that providers with low compassion satisfaction scores were more likely to report being irritable with patients, reducing their standards of care, and have less ability to maintain empathy for their patients. 26 This connection to quality of care was also found in our research. In as much as the respondents in our study spoke of harm reduction work feeling demoralizing and described feelings of frustration, helplessness, and the sense that what they are doing wasn't really helping, they specifically connected these experiences directly to consequences for care -consequences such as social and emotional distancing, disconnection, and apathy. It was in this context that the call for inward-facing training and support for frontline providers was clearly identified, particularly initiatives that would support frontline providers in building resiliency, as well as cultivating, protecting and enhancing compassion and compassion satisfaction. Although more research is required, promising and proposed strategies include the use of social contact approaches to shift perceptions and build compassion, as well as training in trauma and resiliency-informed practice, as identified through this and other related research. 18, 27, 28 More training in, and a better understanding of, harm reduction theory and best practice -particularly in terms of how harm reduction can support and can be an integral component of, of hope, wellness and a potential pathway to recovery -also merged as a key learning need. Equally as important, providers on the front-lines of the opioid crisis identified the value of social contact as a key stigma reduction strategy for improving attitudes, along with the need for interventions that would help them see and believe that wellness and recovery are both real and possible. Notably, these findings are consistent with research in best practices for combatting mental illness-related stigma in healthcare environments. 29, 31 That stigma emerged in this study as first and foremost a problem of low compassion satisfaction is indeed noteworthy. It suggests that existing intervention frameworks that seek to address stigma as a problem of knowledge, attitudes, and behaviours (e.g., 32) may be missing an important element, and that an important avenue for future research would be to develop and elaborate on the theoretical connections between the concepts of stigmatization and compassion satisfaction as a way to better understanding the problem of stigmatization in helping environments.
ReFeRenCeS
